Hims & Hers Health (HIMS) stock rocketed higher today after the telehealth platform operator announced plans to introduce ...

旧金山 - 知名健康与保健公司Hims & Hers Health, Inc.宣布收购新泽西州居家实验室检测机构Sigmund NJ LLC（商业名称为Trybe Labs）。这一战略性收购将为Hims & Hers平台引入居家实验室检测能力，提升个性化医疗服务。

Hims & Hers Health Inc. is expanding beyond its successful foray into providing copycat weight-loss drugs with the ...

After having massive success with off-brand weight-loss drugs, the millennial-focused telehealth company Hims & Hers (HIMS) ...

Hims & Hers Health, Inc. shares surged 17.5% on Wednesday, marking their best performance in a week and hitting fresh highs ...

Hims & Hers Health, Inc., the leading health and wellness platform, today announced its plans to introduce at-home lab ...

Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab ...

New service will enable blood testing for hormone levels, cardiac risk, thyroid function, and more using a blood lancet.

Hims & Hers announced its plans to introduce at-home lab testing through its platform. The company has acquired an at-home lab testing ...

Hims & Hers Health shares reached another all-time high after the company said it plans to introduce at-home lab testing through its platform after buying an at-home testing facility, Sigmund NJ.

By acquiring Sigmund NJ LLC, known as Trybe Labs, Hims & Hers will be able "to support at-home blood draws and more ...